Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases

Clinical trial NCT07008287 · RECRUITING

Trial details

NCT number: NCT07008287
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer

Start date: 2025-06-04
Primary completion: 2027-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.